科学迷社区

像看英超和懂球帝一样看 AI 与 Biotech:最新论文、科研成果、人物、实验室、证据来源、商业化信号和关系图谱集中在一个信息流里。

已审核信号
601
证据来源
721
追踪领域
12
全球总榜诊断与生物标志物93 条匹配动态
publicationBiotecheditor reviewed
Rising signal69

Immunohistochemical and Molecular Biomarkers Bridging Pathogenesis and Precision Medicine in Endometrial Carcinoma: A Systematic Review

原始来源文本: Publication signal: Immunohistochemical and Molecular Biomarkers Bridging Pathogenesis and Precision Medicine in Endometrial Carcinoma: A Systematic Review

AISci 已验证editor reviewed / 1 证据来源
publicationBiotecheditor reviewed
Rising signal63

Oculomics: advances and perspectives from traditional Chinese medicine to modern multimodal biomarkers

原始来源文本: Publication signal: Oculomics: advances and perspectives from traditional Chinese medicine to modern multimodal biomarkers

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal62

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

原始来源文本: Clinical/translation signal: A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal62

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

原始来源文本: Clinical/translation signal: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

AISci 已验证editor reviewed / 1 证据来源
publicationBiotecheditor reviewed
Rising signal62

Emerging Biomarkers in Pediatric Food Allergy: From Mechanistic Endotyping to Precision Diagnosis and Therapeutic Monitoring

原始来源文本: Publication signal: Emerging Biomarkers in Pediatric Food Allergy: From Mechanistic Endotyping to Precision Diagnosis and Therapeutic Monitoring

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal60

Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)

原始来源文本: Clinical/translation signal: Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)

AISci 已验证editor reviewed / 1 证据来源
publicationBiotecheditor reviewed
Rising signal60

Next-Generation Cardiovascular Imaging in Precision Medicine: Integrating Functional Imaging, Artificial Intelligence, Biomarkers, and Personalized Risk Stratification

原始来源文本: Publication signal: Next-Generation Cardiovascular Imaging in Precision Medicine: Integrating Functional Imaging, Artificial Intelligence, Biomarkers, and Personalized Risk Stratification

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal60

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

原始来源文本: Clinical/translation signal: Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal60

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

原始来源文本: Clinical/translation signal: Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

AISci 已验证editor reviewed / 1 证据来源
publicationBiotecheditor reviewed
Rising signal60

Application of Epigenetic biomarkers in the precision medicine for sepsis-induced acute lung injury: From risk stratification to targeted therapy

原始来源文本: Publication signal: Application of Epigenetic biomarkers in the precision medicine for sepsis-induced acute lung injury: From risk stratification to targeted therapy

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal59

More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)

原始来源文本: Clinical/translation signal: More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal59

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

原始来源文本: Clinical/translation signal: Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal59

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

原始来源文本: Clinical/translation signal: Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal59

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

原始来源文本: Clinical/translation signal: Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal58

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

原始来源文本: Clinical/translation signal: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

AISci 已验证editor reviewed / 1 证据来源
clinical updateBiotecheditor reviewed
Rising signal58

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

原始来源文本: Clinical/translation signal: PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

AISci 已验证editor reviewed / 1 证据来源